World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 14 January 2013
Main ID:  NCT01018888
Date of registration: 24/11/2009
Primary sponsor: Aurolab
Public title: Safety and Efficacy Study of Artificial Cornea AuroKPro
Scientific title: Clinical Assessment of Auro KPro
Date of first enrolment: August 2010
Target sample size: 20
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01018888
Study type:  Interventional
Study design:  Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
India
Contacts
Name:   Mr. Gobinath , B.Pharm
Address: 
Telephone: 0452-4356100
Email: clinicalresearch@aravind.org
Affiliation: 
Name:   Mr.Karthikumar S, M.Pharm
Address: 
Telephone: 0452-3096100
Email: crd@aurolab.com
Affiliation: 
Name:   Dr. Jeena Mascarenhas, MBBS, MS
Address: 
Telephone:
Email:
Affiliation:  Aravind Eye Hospital, Madurai
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age more than 20 years

- Willing to participate and review on schedule

- Multiple failed grafts with poor prognosis for regrafting

- Adequate tear film and lid function

- Projection of light in all quadrants

- Bilateral blind

Exclusion Criteria:

- Reasonable chance of success with keratoplasty

- Autoimmune disease such as Stevens Johnson Syndrome, Pemphigoid

- End stage glaucoma

- Retinal detachment



Age minimum: 20 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Corneal Transplantation
Intervention(s)
Device: Auro KPro (Keratoprosthesis)
Primary Outcome(s)
Visual Acuity [Time Frame: 1st Month, 2nd Month, 3rd Month,5th Month, 7th Month, 9th Month and 12th Month]
Secondary Outcome(s)
Retention of the device [Time Frame: 1st Month, 2nd Month, 3rd Month,5th Month, 7th Month, 9th Month and 12th Month]
Secondary ID(s)
1PN1010941
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history